Biohaven's migraine therapy shows rapid pain relief in late-stage study – Reuters

Biohaven’s migraine headache treatment reveals quick discomfort alleviation in late-stage research study – Reuters

Biohaven Pharmaceutical (BHVN.N) claimed on Monday its intranasal spray for migraine headache satisfied the major objectives in the drugmaker’s late-stage research study, revealing fast discomfort relief.Read More …